April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Aberrant Secretion Of Insulin-like Growth Factor-1 By Orbital Fibroblasts From Patients With Thyroid Associated Ophthalmopathy In Vitro: Implications For Disease Pathogenesis
Author Affiliations & Notes
  • Delu Song
    Dept. of Ophthalmology, Peking Union Medical College Hospital, Beijing, China
  • Renyan Wang
    Dept. of Ophthalmology, Peking Union Medical College Hospital, Beijing, China
  • Yong Zhong
    Dept. of Ophthalmology, Peking Union Medical College Hospital, Beijing, China
  • Fangtian Dong
    Dept. of Ophthalmology, Peking Union Medical College Hospital, Beijing, China
  • Footnotes
    Commercial Relationships  Delu Song, None; Renyan Wang, None; Yong Zhong, None; Fangtian Dong, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2940. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Delu Song, Renyan Wang, Yong Zhong, Fangtian Dong; Aberrant Secretion Of Insulin-like Growth Factor-1 By Orbital Fibroblasts From Patients With Thyroid Associated Ophthalmopathy In Vitro: Implications For Disease Pathogenesis. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2940.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the secretion effect of Insulin-like Growth Factor-1 (IGF-1) by orbital fibroblasts from patients with Thyroid Associated Ophthalmopathy (TAO) and to determine whether serum levels of total and free IGF-1 are normal and its relationship with clinical activity scores.

Methods: : Eighteen consecutive patients with TAO, sixteen age and sex matched controls were studied. Total and free IGF-1 in serum were determined using a noncompetitive time resolved radioimmunoassy kit. The IGF-1 concentration in cell cultural media was determined by Elisa kit.

Results: : Total and free IGF-1 levels in patients were similar to controls and did not show any significant difference (Total IGF-1: TAO patients=121±52 Control=149±45, Free IGF-1: TAO patients=0.54±0.19 Control=0.79±0.32). Furthermore, no statistically significant differences emerged in above mentioned parameters and clinical activity scores. Radioimmunoassay demonstrated that orbital fibroblasts from both TAO patients and normal controls produce IGF-1 and this production continued over a 72 hour period. IGF-1 production in orbital fibroblasts from TAO patients is significant more than normal controls.

Conclusions: : No relationship was found between the IGF-1 levels in serum of TAO patients with clinical activity scores. Autocrine of IGF-1 from orbital fibroblast is over activated in TAO patients and may play a significant role in pathogenesis of TAO.

Clinical Trial: : www.pumchkyc.net, 20080502012

Keywords: autoimmune disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×